Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine, which is for adults aged 60 years and older. It is well to be… Read More

Summer’s here and you’re probably not thinking about respiratory syncytial virus (RSV. But the time to think about it is before RSV season is officially upon us. According to t… Read More

Just a short year after GSK and Pfizer won approvals for their respiratory syncytial virus (RSV) vaccines, Moderna has received the US Food and Drug Administration (FDA)’s stamp of app… Read More

URGENT CARE FREQUENTLY ASKED QUESTIONSWhy Kinder Pediatric Urgent Care?We understand that nothing is more important than the health and well-being of your ch… Read More

Dow rose 568 (with buying into the close), advancers over decliners 5-2 & NAZ inched up pennies after being in the red all day.  The MLP index gained 3+ to the 275s & the REIT i… Read More

Why Kinder Pediatric Urgent Care?We understand that nothing is more important than the health and well-being of your child.At… Read More

Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy. May 29, 2024 View… Read More

Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy. May 29, 2024 View in… Read More

Since ancient times, herbs have been used as natural treatments for various illnesses, including viral infections. Due to their concentration of potent plant compounds, many herbs help fight… Read More

Victoria is grappling with an infectious “soup” of influenza, COVID-19, and respiratory syncytial virus (RSV), resulting in increased hospitalisations and sick days across the st… Read More

The National Advisory Committee on Immunization is recommending a universal immunization program against respiratory syncytial virus, or RSV, for all infants. * This article was originally… Read More

May 2024 | Report Format: Electronic (PDF) Canada Pharmaceutical Market Growth & Trends The Canada pharmaceutical market size is expected to reach a value of USD 76.86 billion… Read More

Influenza, commonly known as the flu, remains a significant public health challenge globally, characterized by seasonal outbreaks and the potential for pandemic occurrences. Influenza viruse… Read More

There are many things you will share with your baby: your wisdom, your love, your excitement, and your joy. Did you know that you can also share protection against many illnesses with your b… Read More

Dow climbed 322 (near session highs), advancers over decliners better than 3-1 & NAZ jumped 235.  The MLP index added 3 to the 278s after its recent decline & the REIT index ros… Read More

GSK raises profit outlook on strong vaccine, HIV drug sales By Eva Mathews and Maggie Fick (Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common re… Read More

 Introduction: Exploring the Landscape of Childhood IllnessesChildhood is a time of exploration, growth, and discovery, but it's also a period when children are susceptible to various i… Read More

Sinus infections, medically known as sinusitis, can leave you feeling miserable with symptoms like nasal congestion, facial pain, and headaches. As you battle through the discomfort, you may… Read More

The success of mRNA vaccine technology as seen during the recent Covid-19 pandemic offers hope for using the platform to reduce preventable illness across multiple disease areas, according t… Read More

Saudi Arabia is providing RSV Vaccine to Elders to combat Respiratory risksCitizens and Residents of the Kingdom of Saudi Arabia who are of 60 years and above will now be able to get the Res… Read More

Presented by Pharmaceutical Care Management Association: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy… Read More

Introduction Bronchitis is a common respiratory condition characterized by inflammation of the bronchial tubes, which carry air to and from the lungs. It can be caused by viral or bacterial… Read More

Pfizer RSV shot meets goals in trial of high-risk adults under age 60 By Michael Erman (Reuters) – Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well… Read More

Dow dropped 239, decliners modestly ahead of advancers & NAZ retreated 57.  The MLP index was off 1+ to the 285s & the REIT index went up 2+ to the 381s.  Junk bond funds w… Read More

Point of Care Diagnostics Market in terms of revenue was estimated to be worth $49.7 billion in 2023 and is poised to reach $77.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028… Read More

Respiratory tract infections are very common illnesses that affect the nose, throat, airways or lungs. Though usually mild, they can sometimes lead to serious complications if left untreated… Read More

In the intricate world of medical billing and insurance claims, accurate CPT code selection is paramount. CPT codes act as a universal language, streamlining communication between healthcare… Read More

New Delhi: Pharmaceutical major Sanofi Healthcare India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation CDSCO to i… Read More

(CTN News) – Earlier this week, Moderna announced that Blackstone’s life sciences arm would contribute $750 million to its flu vaccine development, supporting the company’s… Read More

Pfizer Inc. (NYSE: PFE) today announced top-line ABRYSVO® vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adults 60 years of age and older following a seco… Read More

 The global influenza diagnostic market size reached USD 1.69 billion in 2023 and is predicted to hit around USD 2.97 billion by 2033, growing at a CAGR of 5.80% from 2024 to 2033. … Read More

 Croup and whooping cough are both respiratory illnesses that can affect children, causing symptoms such as coughing and difficulty breathing. While they may share some similarities, th… Read More

The names Alejandra Gurtman, MD, and Barbara Pahud, MD, probably don't ring a bell. But they should. Both Dr. Gurtman and Dr. Pahud work for Pfizer and played a major role in the creation of… Read More

Wilmington, Delaware, United States, 2024-Mar-08 — /EPR Network/ — The Respiratory Syncytial Virus (RSV) Therapeutics Market focuses on the development and commercialization of p… Read More

Discover the RSV vaccine's impact on health defense! Unravel its effectiveness, safety, and more in this comprehensive guide. FitnessFusion - Yo, health warriors! Ready to explore the realms… Read More

introduction lets see what are the ayurvedic remedy for cough The epidemic brought the world to a halt. This included the spreading of diseases like common colds and coughs. Lockdo… Read More

New Delhi, March 9 (IANS) The flu season in the US, this year, has claimed more than a hundred children’s lives, according to latest estimates from the country’s Centers for Dise… Read More

Presented by the Coalition to Protect America's Health Care: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy… Read More

Presented by Better Medicare Alliance: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy… Read More

The Centers for Disease Control and Prevention (CDC) has relaxed its recommendations for preventing the spread of COVID-19, citing a decline in hospitalizations and deaths caused by the… Read More

Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness through a second year of respiratory… Read More

The CDC has changed its COVID-19 guidelines to bring them more in line with RSV and the flu. The USPS has been delivering free COVID-19 tests to US households off and on since Sept. 2022.Tw… Read More

 The pregnancy medication market size is poised to grow by $ 135.43 billion by 2033 from $ 39.68 billion in 2023, exhibiting a CAGR of 13.06% during the forecast period 2024-2033. Key… Read More

During the months of January to March, a familiar trend emerges – an increase in viral infections that can leave many feeling under the weather. Common culprits like adenovirus, influe… Read More

GlaxoSmithKline’s (GSK) Arexvy and Pfizer’s Abrysvo are the first-ever approved vaccines against respiratory syncytial virus (RSV). The vaccines received approvals from the US… Read More